Exogenous ochronosis. An update on clinical features, causative agents and treatment options.
about
On the ocular findings in ochronosis: a systematic review of literaturePostinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of colorExogenous OchronosisExogenous ochronosis: case report and literature reviewHydroquinone and its analogues in dermatology - a risk-benefit viewpointHydroquinone�?�what is it's future?Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment.Established treatments of skin hypermelanoses.Topical treatment of melasma.Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review.Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.Natural options for the management of hyperpigmentation.Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis.Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy siteFacial hyperpigmentation: causes and treatment.Erbium-doped yttrium aluminium garnet ablative laser treatment for endogenous ochronosis.Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments.Exogenous ochronosis After Prolonged Use of Topical Hydroquinone (2%) in a 50-Year-Old Indian Female.Skin Bleaching and Dermatologic Health of African and Afro-Caribbean Populations in the US: New Directions for Methodologically Rigorous, Multidisciplinary, and Culturally Sensitive Research.Postinflammatory hyperpigmentation.Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?Lack of pregnancy warnings on over-the-counter dermatologic products containing potentially harmful hydroquinone.Use of skin-lightening products among selected urban communities in Accra, Ghana.Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment.Use of Skin-Whitening Products by Sudanese Undergraduate Females: a Survey.Pigmented colloid milium associated with exogenous ochronosis in a farmer with long-term exposure to fertilizers.Ochronotic arthritis of bilateral knees: a case reportReduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial.Structural and kinetic considerations on the catalysis of deoxyarbutin by tyrosinase.Toxic effects of skin-lightening products in Canadian immigrants.Thai plants with high antioxidant levels, free radical scavenging activity, anti-tyrosinase and anti-collagenase activity.Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis.Clinical evaluation of a dioic acid-based formulation on facial skin in an Indian population.Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
P2860
Q21260367-93CEBB9B-A478-4C4A-9F76-625421EEAF8AQ24631938-73ABF5F0-F9C2-44F6-B0D3-AE19A1664A4FQ26775140-6EFED89E-2C35-46E8-BB65-EED4D9F1ECF3Q26860322-4AD65647-AE2E-4989-B541-DA3FFEDB6EE1Q28279624-851EC15D-BE15-4B31-B7EF-4DFCDCEA0559Q29032107-00C02994-FE98-4F53-97AE-7EA3FE32E98DQ30240135-BA33DCC7-A6B3-455F-BECF-58AB54946442Q33294994-764A859C-FBDC-4189-BB5A-CDDE9DD5F348Q33595442-03C5BB0A-5C43-4982-A2FC-DD18A1978E07Q33723553-952BDCDB-338C-4D4A-AD9B-031AF31A8BCCQ33829098-9ACA7061-F5B4-4E1E-8960-9D2218BB0A7FQ34188297-BF7A0563-31AC-48FE-9804-C60377C160A3Q34569502-6803D13A-0B5F-4A01-A10B-124378539C52Q34928478-3B33540A-57B7-4C59-AB05-F48E71CA19EFQ35010478-F30BA578-7D54-441D-9318-4175800AE2C4Q35319910-685DDCAB-33A8-4100-BDF3-A45BAD37FD7CQ35594566-A5F3801F-AF5A-419D-8882-26139420946EQ36352344-DA9A63FD-8E5C-4705-AD0C-D942DF2B4161Q37432282-FFB24DCD-097B-4AF2-B235-7B4EFE6D0E96Q37586545-2AAFFE94-452B-4268-A546-D992920B8F0FQ37679966-806ED49D-5448-46CC-A438-F6E5285B55F7Q38867439-C64AAD95-1209-49D8-A7CF-945533268198Q39108906-75101BFB-EB92-433F-A45F-2DAA7A69755EQ39960283-44749CAA-90E9-42A9-A5E9-49FCB9D1BD06Q40875118-E01D94D5-CEA4-4B76-BFFE-3562F19A59E7Q41979670-94B73501-92A5-4D89-AB14-295D02CF6DE5Q42365016-FC588B49-51A7-4216-878D-794D363DAD08Q45736486-17D235FA-89BB-4104-88B6-4BD9F1FCF2A9Q45931311-9CAF4896-AEDF-4788-AD4E-81ED757B4692Q46242662-5D170837-9B71-4590-B771-0724DF8D11A1Q46264702-C5B1CCA1-CCB1-4FAD-B115-D2F711D5DCC7Q46598192-891DF979-8FEE-4E3D-A774-E5ECA263EB5BQ50252325-9F794DD2-137E-4535-A3BB-9C861824B0F3Q51309354-CD767237-017A-4886-954F-070A1C646BBCQ53492069-9C7079E0-13F8-49E2-A713-D756C4047214Q54382926-353110C1-BF05-44F4-A3B5-B3169E6252C9
P2860
Exogenous ochronosis. An update on clinical features, causative agents and treatment options.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Exogenous ochronosis. An updat ...... agents and treatment options.
@ast
Exogenous ochronosis. An updat ...... agents and treatment options.
@en
type
label
Exogenous ochronosis. An updat ...... agents and treatment options.
@ast
Exogenous ochronosis. An updat ...... agents and treatment options.
@en
prefLabel
Exogenous ochronosis. An updat ...... agents and treatment options.
@ast
Exogenous ochronosis. An updat ...... agents and treatment options.
@en
P1476
Exogenous ochronosis. An updat ...... agents and treatment options.
@en
P2093
P304
P356
10.2165/00128071-200102040-00002
P577
2001-01-01T00:00:00Z
P6179
1036105165